Bacterial Resistance to Antimicrobial Agents
Open accessThe DOI matches its Crossref record; 173 of the 173 references it cites were found in a registry or an index.
Abstract
Bacterial pathogens as causative agents of infection constitute an alarming concern in the public health sector. In particular, bacteria with resistance to multiple antimicrobial agents can confound chemotherapeutic efficacy towards infectious diseases. Multidrug-resistant bacteria harbor various molecular and cellular mechanisms for antimicrobial resistance. These antimicrobial resistance mechanisms include active antimicrobial efflux, reduced drug entry into cells of pathogens, enzymatic metabolism of antimicrobial agents to inactive products, biofilm formation, altered drug targets, and protection of antimicrobial targets. These microbial systems represent suitable focuses for investigation to establish the means for their circumvention and to reestablish therapeutic effectiveness. This review briefly summarizes the various antimicrobial resistance mechanisms that are harbored within infectious bacteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Tacconelli, E., Carrara, E., Savoldi, A., Harbarth, S., Mendelson, M., Monnet, D. L., Pulcini, C., Kahlmeter, G., Kluytmans, J., Carmeli, Y., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30753-3 · Cited by 6,142 · cited 1×
“The World Health Organization (WHO) has recognized carbapenem-resistant Enterobacteriaceae (CRE) as a serious global health scourge for which the development of new antimicrobials is critically needed [35].”
BackgroundMolecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Molecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092
Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,491
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834 · cited 2×
“Such pathogenic bacteria produce alarming numbers in terms of morbidity and mortality outcomes [2,3].”
BackgroundMechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367 · cited 7×
“The β-lactam antibiotics inhibit the bacterial proteins known as penicillin-binding proteins (PBPs), which perform the critical role of peptide cross-linking during peptidoglycan cell wall biosynthesis.”
BackgroundMethodInfluentialPao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297
Food Animals and Antimicrobials: Impacts on Human Health
Marshall, B. M., & Levy, S. B. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-11 · Cited by 2,241
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
Molecular mechanisms that confer antibacterial drug resistance
Walsh, C. (2000) · Nature · doi:10.1038/35021219 · Cited by 1,578
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
Crystal structures explain functional properties of two E. coli porins
Cowan, S. W., Schirmer, T., Rummel, G., Steiert, M., Ghosh, R., Pauptit, R. A., Jansonius, J. N., & Rosenbusch, J. P. (1992) · Nature · doi:10.1038/358727a0 · Cited by 1,520
Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems
Davidson, A. L., Dassa, E., Orelle, C., & Chen, J. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-07 · Cited by 1,420
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Structure of a bacterial multidrug ABC transporter
Dawson, R. J. P., & Locher, K. P. (2006) · Nature · doi:10.1038/nature05155 · Cited by 1,279
Structure and function of bacterial outer membrane proteins: barrels in a nutshell
Koebnik, R., Locher, K. P., & Van Gelder, P. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01983.x · Cited by 1,202
Erythromycin resistance by ribosome modification
Weisblum, B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.577 · Cited by 1,008 · cited 2×
“The 50S ribosomal unit serves as the binding site for macrolide, lincosamide, and streptogramin B [57].”
BackgroundPeterson, E., & Kaur, P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02928 · Cited by 1,006
Crystal structure of bacterial multidrug efflux transporter AcrB
Murakami, S., Nakashima, R., Yamashita, E., & Yamaguchi, A. (2002) · Nature · doi:10.1038/nature01050 · Cited by 986
The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1994 · Cited by 939
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897 · cited 1×
“Enzymatic modification of antibiotics by the transfer of functional groups, such as acyl, glycosyl, ribosyl, nucleotidyl, phosphoryl, or thiol groups, confers resistance to a range of antibiotics, including aminoglycosides, rifamycins, macrolides, epoxides, and chloramphenicol [44].”
BackgroundPast and Present Perspectives on β-Lactamases
Bush, K. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01076-18 · Cited by 832
Evans, B. A., & Amyes, S. G. B. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-13 · Cited by 815
The Science of Antibiotic Discovery
Lewis, K. (2020) · Cell · doi:10.1016/j.cell.2020.02.056 · Cited by 797
Tseng, T., Gratwick, K. S., Kollman, J. M., Park, D., Nies, D. H., Goffeau, A., & Saier, M. H. (1999) · PubMed · Cited by 729
Founou, R. C., Founou, L. L., & Essack, S. Y. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189621 · Cited by 710
Structure, biochemistry and mechanism of action of glycopeptide antibiotics
Reynolds, P. E. (1989) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967563 · Cited by 699
Bugg, T. D. H., Wright, G. D., Dutka-Malen, S., Arthur, M., Courvalin, P., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 650
ABC transporters: physiology, structure and mechanism – an overview
Higgins, C. F. (2001) · Research in Microbiology · doi:10.1016/s0923-2508(01)01193-7 · Cited by 641
Industrial Food Animal Production, Antimicrobial Resistance, and Human Health
Silbergeld, E. K., Graham, J., & Price, L. B. (2008) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.29.020907.090904 · Cited by 635
Antibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives
Garneau-Tsodikova, S., & Labby, K. J. (2016) · MedChemComm · doi:10.1039/c5md00344j · Cited by 576
The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria
Swaney, S. M., Aoki, H., Ganoza, M. C., & Shinabarger, D. L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3251 · Cited by 555
An enzyme from bacteria able to destroy penicillin. 1940.
Abraham, E. P., & Chain, E. B. (1988) · PubMed · Cited by 531
Tetracycline antibiotics and resistance mechanisms
Nguyen, F., Starosta, A. L., Arenz, S., Sohmen, D., Dönhöfer, A., & Wilson, D. N. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0292 · Cited by 528
Formation of the glycan chains in the synthesis of bacterial peptidoglycan
Heijenoort, J. V. (2001) · Glycobiology · doi:10.1093/glycob/11.3.25r · Cited by 526
Bacterial stress responses as determinants of antimicrobial resistance
Poole, K. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks196 · Cited by 519
NGL viewer: web-based molecular graphics for large complexes
Rose, A. S., Bradley, A. R., Valasatava, Y., Duarte, J. M., Prlić, A., & Rose, P. W. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty419 · Cited by 489
Bera, A., Herbert, S., Jakob, A., Vollmer, W., & Götz, F. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04446.x · Cited by 481
Efflux pump inhibitors for bacterial pathogens: From bench to bedside
Sharma, A., Gupta, V. K., & Pathania, R. (2019) · Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2079_17 · Cited by 458
Murein (peptidoglycan) structure, architecture and biosynthesis in Escherichia coli
Vollmer, W., & Bertsche, U. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.06.007 · Cited by 451
Ribosomal Protection Proteins and Their Mechanism ofTetracyclineResistance
Connell, S. R., Tracz, D. M., Nierhaus, K. H., & Taylor, D. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3675-3681.2003 · Cited by 449 · cited 10×
“Structural studies have shown that both TetM and TetO overlap the tetracycline binding site on the ribosome, which indicates that the resistance of drugs is through direct displacement from the ribosome [88,94].”
BackgroundInfluentialMolecular mechanisms of antibiotic resistance
Wright, G. D. (2011) · Chemical Communications · doi:10.1039/c0cc05111j · Cited by 443
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
Vila, J., Martí, S., & Sánchez-Céspedes, J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl509 · Cited by 436
Bacterial resistance to antibiotics: Modified target sites
LAMBERT, P. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.003 · Cited by 424
Structure, function and regulation of Pseudomonas aeruginosa porins
Chevalier, S., Bouffartigues, E., Bodilis, J., Maillot, O., Lesouhaitier, O., Feuilloley, M. G. J., Orange, N., Dufour, A., & Cornelis, P. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux020 · Cited by 423
Resistance of Staphylococcus aureus to the Action of Penicillin.
Rammelkamp, C. H., & Maxon, T. (1942) · Experimental Biology and Medicine · doi:10.3181/00379727-51-13986 · Cited by 416
Doron, S., & Davidson, L. E. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0358 · Cited by 415
Dawson, R. J. P., & Locher, K. P. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.073 · Cited by 406
Active efflux, a common mechanism for biocide and antibiotic resistance
Levy, S. B. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.4.x · Cited by 401
Bagshaped Macromolecules—A New Outlook on Bacterial Cell Walls
Weidel, W., & Pelzer, H. (1964) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470122716.ch5 · Cited by 399
Multidrug efflux transporters in the MATE family
Kuroda, T., & Tsuchiya, T. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.012 · Cited by 396
Jaurin, B., & Grundström, T. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4897 · Cited by 390
The permeability of the wall fabric of Escherichia coli and Bacillus subtilis
Demchick, P., & Koch, A. L. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.3.768-773.1996 · Cited by 389
TetX Is a Flavin-dependent Monooxygenase Conferring Resistance to Tetracycline Antibiotics
Yang, W., Moore, I. F., Koteva, K. P., Bareich, D. C., Hughes, D. W., & Wright, G. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409573200 · Cited by 364
Novel Macrolide-Specific ABC-Type Efflux Transporter in Escherichia coli
Kobayashi, N., Nishino, K., & Yamaguchi, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.19.5639-5644.2001 · Cited by 353
Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview
Vivas, R., Barbosa, A. A. T., Dolabela, S. S., & Jain, S. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2018.0319 · Cited by 343
β-Lactamases of Kluyvera ascorbata , Probable Progenitors of Some Plasmid-Encoded CTX-M Types
Humeniuk, C., Arlet, G., Gautier, V., Grimont, P., Labia, R., & Philippon, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3045-3049.2002 · Cited by 338
Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review
Zhen, X., Lundborg, C. S., Sun, X., Hu, X., & Dong, H. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0590-7 · Cited by 337
The drug/metabolite transporter superfamily
Jack, D. L., Yang, N. M., & H. Saier, M. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02265.x · Cited by 330
Fosfomycin: Mechanism and Resistance
Silver, L. L. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025262 · Cited by 320
Rosenfeld, Y., & Shai, Y. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.05.017 · Cited by 318
Paulsen, I. T., Skurray, R. A., Tam, R., Saier, M. H., Turner, R. J., Weiner, J. H., Goldberg, E. B., & Grinius, L. L. (1996) · Molecular Microbiology · doi:10.1111/j.1365-2958.1996.tb02462.x · Cited by 317
Morse, S. A., Johnson, S. R., Biddle, J. W., & Roberts, M. C. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.30.5.664 · Cited by 313
Antimicrobial Resistance to Linezolid
Meka, V. G., & Gold, H. S. (2004) · Clinical Infectious Diseases · doi:10.1086/423841 · Cited by 309
Plasmid-mediated quinolone resistance: an update
Rodríguez-Martínez, J. M., Velasco, C., Pascual, Á., Cano, M. E., Martínez-Martínez, L., Martínez-Martínez, L., & Pascual, Á. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0120-2 · Cited by 306 · cited 5×
“Furthermore, multidrug-resistant bacteria have developed mechanisms that confer the DNA transfer of genetic determinants of resistance to pathogenic species in the clinical setting, the food production industry, the human gut, and in agriculture [9].”
BackgroundInfluentialPrystowsky, J., Siddiqui, F., Chosay, J., Shinabarger, D. L., Millichap, J., Peterson, L. R., & Noskin, G. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2154-2156.2001 · Cited by 302
ABC-transporters: implications on drug resistance from microorganisms to human cancers
Lage, H. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00203-6 · Cited by 298
Chloramphenicol Acetyltransferase: Enzymology and Molecular Biology
Shaw, W. V. (1983) · Critical Reviews in Biochemistry · doi:10.3109/10409238309102789 · Cited by 297
The structure of cephalosporin C
Abraham, E. P., & Newton, G. G. F. (1961) · Biochemical Journal · doi:10.1042/bj0790377 · Cited by 296
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
X-ray structure of EmrE supports dual topology model
Chen, Y.-J., Pornillos, O., Lieu, S., Ma, C., Chen, A. P., & Chang, G. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709387104 · Cited by 277
Common Folds and Transport Mechanisms of Secondary Active Transporters
Shi, Y. (2013) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-083012-130429 · Cited by 276
The multidrug/oligosaccharidyl‐lipid/polysaccharide (MOP) exporter superfamily
Hvorup, R. N., Winnen, B., Chang, A. B., Jiang, Y., Zhou, X., & Saier, M. H. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03418.x · Cited by 256
VanD-type glycopeptide-resistant Enterococcus faecium BM4339
Perichon, B., Reynolds, P., & Courvalin, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.9.2016 · Cited by 244
Prammananan, T., Sander, P., Brown, B. A., Frischkorn, K., Onyi, G. O., Zhang, Y., Böttger, E. C., & Wallace, Jr. (1998) · The Journal of Infectious Diseases · doi:10.1086/515328 · Cited by 241
VanE, a New Type of Acquired Glycopeptide Resistance in Enterococcus faecalis BM4405
Fines, M., Perichon, B., Reynolds, P., Sahm, D. F., & Courvalin, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2161 · Cited by 241
Heterogeneity in efflux pump expression predisposes antibiotic-resistant cells to mutation
El Meouche, I., & Dunlop, M. J. (2018) · Science · doi:10.1126/science.aar7981 · Cited by 240
Bacterial Wall as Target for Attack: Past, Present, and Future Research
Koch, A. L. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.4.673-687.2003 · Cited by 231
Modulating the outer membrane with small RNAs
Guillier, M., Gottesman, S., & Storz, G. (2006) · Genes & Development · doi:10.1101/gad.1457506 · Cited by 226
Canu, A., Malbruny, B., Coquemont, M., Davies, T. A., Appelbaum, P. C., & Leclercq, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.125-131.2002 · Cited by 218
Structural basis for TetM-mediated tetracycline resistance
Dönhöfer, A., Franckenberg, S., Wickles, S., Berninghausen, O., Beckmann, R., & Wilson, D. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208037109 · Cited by 217
Bench-to-bedside review: The role of β-lactamases in antibiotic-resistant Gram-negative infections
Bush, K. (2010) · Critical Care · doi:10.1186/cc8892 · Cited by 217
Target protection as a key antibiotic resistance mechanism
Wilson, D. N., Hauryliuk, V., Atkinson, G. C., & O’Neill, A. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-0386-z · Cited by 213
Genetic Characterization of vanG , a Novel Vancomycin Resistance Locus of Enterococcus faecalis
McKessar, S. J., Berry, A. M., Bell, J. M., Turnidge, J. D., & Paton, J. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3224-3228.2000 · Cited by 210
Ebbensgaard, A., Mordhorst, H., Aarestrup, F. M., & Hansen, E. B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02153 · Cited by 205
Understanding antibiotic resistance via outer membrane permeability
Ghai, I., & Ghai, S. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s156995 · Cited by 204
The structure of OmpF porin in a tetragonal crystal form
Cowan, S., Garavito, R., Jansonius, J., Jenkins, J., Karlsson, R., König, N., Pai, E., Pauptit, R., Rizkallah, P., Rosenbusch, J., et al. (1995) · Structure · doi:10.1016/s0969-2126(01)00240-4 · Cited by 197
Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr
Baysarowich, J., Koteva, K., Hughes, D. W., Ejim, L., Griffiths, E., Zhang, K., Junop, M., & Wright, G. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711939105 · Cited by 194
Secondary solute transport in bacteria
Poolman, B., & Konings, W. N. (1993) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(93)90003-x · Cited by 192
Ma, B., Fang, C., Lu, L., Wang, M., Xue, X., Zhou, Y., Li, M., Hu, Y., Luo, X., & Hou, Z. (2019) · Nature Communications · doi:10.1038/s41467-019-11503-3 · Cited by 181
ABC transporters: how small machines do a big job
Davidson, A. L., & Maloney, P. C. (2007) · Trends in Microbiology · doi:10.1016/j.tim.2007.09.005 · Cited by 180
ABC transporters: a riddle wrapped in a mystery inside an enigma
Jones, P. M., O’Mara, M. L., & George, A. M. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.06.004 · Cited by 178
Suzuki, Y., Katsukawa, C., Tamaru, A., Abe, C., Makino, M., Mizuguchi, Y., & Taniguchi, H. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.5.1220-1225.1998 · Cited by 177
Billot-Klein, D., Gutmann, L., Sablé, S., Guittet, E., & van Heijenoort, J. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.8.2398-2405.1994 · Cited by 173
AcrB: a mean, keen, drug efflux machine
Kobylka, J., Kuth, M. S., Müller, R. T., Geertsma, E. R., & Pos, K. M. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14239 · Cited by 171
Efflux pump activity potentiates the evolution of antibiotic resistance across S. aureus isolates
Papkou, A., Hedge, J., Kapel, N., Young, B., & MacLean, R. C. (2020) · Nature Communications · doi:10.1038/s41467-020-17735-y · Cited by 170
Xiong, L., Kloss, P., Douthwaite, S., Andersen, N. M., Swaney, S., Shinabarger, D. L., & Mankin, A. S. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.19.5325-5331.2000 · Cited by 169
Substrate-bound structure of the E. coli multidrug resistance transporter MdfA
Heng, J., Zhao, Y., Liu, M., Liu, Y., Fan, J., Wang, X., Zhao, Y., & Zhang, X. C. (2015) · Cell Research · doi:10.1038/cr.2015.94 · Cited by 168
Andersen, J., He, G.-X., Kakarla, P., KC, R., Kumar, S., Lakra, W., Mukherjee, M., Ranaweera, I., Shrestha, U., Tran, T., et al. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120201487 · Cited by 167
Self-citationSirot, J., Chanal, C., Petit, A., Sirot, D., Labia, R., & Gerbaud, G. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.850 · Cited by 160
Saier, M. H. (1998) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60130-7 · Cited by 159
Structural basis of RND-type multidrug exporters
Yamaguchi, A., Nakashima, R., & Sakurai, K. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00327 · Cited by 159
Linezolid-resistant enterococci: report of the first isolates in the United Kingdom
Auckland, C. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf246 · Cited by 150
Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance
Lagadinou, M., Onisor, M. O., Rigas, A., Musetescu, D.-V., Gkentzi, D., Assimakopoulos, S. F., Panos, G. Z., & Marangos, M. N. (2020) · Antibiotics · doi:10.3390/antibiotics9030107 · Cited by 148
Mechanism of tetracycline resistance by ribosomal protection protein Tet(O)
Li, W., Atkinson, G. C., Thakor, N. S., Allas, Ü., Lu, C.-C., Chan, K.-Y., Tenson, T., Schulten, K., Wilson, K. S., Hauryliuk, V., et al. (2013) · Nature Communications · doi:10.1038/ncomms2470 · Cited by 147 · cited 1×
“Structural studies have shown that both TetM and TetO overlap the tetracycline binding site on the ribosome, which indicates that the resistance of drugs is through direct displacement from the ribosome [88,94].”
Hassan, K. A., Liu, Q., Elbourne, L. D. H., Ahmad, I., Sharples, D., Naidu, V., Chan, C. L., Li, L., Harborne, S. P. D., Pokhrel, A., et al. (2018) · Research in Microbiology · doi:10.1016/j.resmic.2018.01.001 · Cited by 145
Look and Outlook on Enzyme-Mediated Macrolide Resistance
Golkar, T., Zieliński, M., & Berghuis, A. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01942 · Cited by 142
Mechanism and Diversity of the Erythromycin Esterase Family of Enzymes
Morar, M., Pengelly, K., Koteva, K. K., & Wright, G. D. (2012) · Biochemistry · doi:10.1021/bi201790u · Cited by 141
Biochemistry of Bacterial Multidrug Efflux Pumps
Kumar, S. H., & Varela, M. F. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13044484 · Cited by 140
Self-citationLeakage of periplasmic proteins from Escherichia coli mediated by polymyxin B nonapeptide
DIXON, R. A., & Chopra, I. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.5.781 · Cited by 140
Ambrose, K. D., Nisbet, R., & Stephens, D. S. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4203-4209.2005 · Cited by 138
Bacterial porins: structure and function
Schulz, G. E. (1993) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(93)90143-e · Cited by 135
Masi, M., & Pagès, J. (2013) · The Open Microbiology Journal · doi:10.2174/1874285801307010022 · Cited by 135
Energy coupling in secondary active transport
West, I. C. (1980) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(80)90586-6 · Cited by 133
Dissemination of the tetM tetracycline resistance determinant to Ureaplasma urealyticum
Roberts, M. C., & Kenny, G. E. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.2.350 · Cited by 127
Effect of mutations in the A site of 16 S rRNA on aminoglycoside antibiotic-ribosome interaction
Recht, M. I., Douthwaite, S. R., Dahlquist, K. D., & Puglisi, J. D. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2446 · Cited by 124
Wang, G., & Taylor, D. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1952 · Cited by 121
Tet(M)-promoted release of tetracycline from ribosomes is GTP dependent
Burdett, V (1996) · Journal of Bacteriology · doi:10.1128/jb.178.11.3246-3251.1996 · Cited by 121
Enzymic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance.
BARTHÉLÉMY, P., AUTISSIER, D., Gerbaud, G., & Courvalin, P. M. (1984) · The Journal of Antibiotics · doi:10.7164/antibiotics.37.1692 · Cited by 118
Multidrug efflux transporter, AcrB—the pumping mechanism
Murakami, S. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.06.007 · Cited by 116
Bogomolnaya, L. M., Andrews, K. D., Talamantes, M., Maple, A., Ragoza, Y., Vázquez‐Torres, A., & Andrews‐Polymenis, H. L. (2013) · mBio · doi:10.1128/mbio.00630-13 · Cited by 116
Molecular mechanisms of bacterial resistance to antimicrobial agents
Kumar, S. H., & Varela, M. F. (2013) · Cited by 116
Self-citationRoss, J. I., Eady, E. A., Cove, J. H., Jones, C. E., Ratyal, A. H., Miller, Y. W., Vyakrnam, S., & Cunliffe, W. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1162 · Cited by 114
SMR-type multidrug resistance pumps.
Chung, Y. J., & Saier, M. H. (2001) · PubMed · Cited by 112
Sinha, S., Zheng, L., Mu, Y., Ng, W. J., & Bhattacharjya, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-18102-6 · Cited by 112
Kumar, S., Lekshmi, M., Parvathi, A., Ojha, M., Wenzel, N., & Varela, M. F. (2020) · Microorganisms · doi:10.3390/microorganisms8020266 · Cited by 112
Self-citationZimmermann, S., Klinger-Strobel, M., Bohnert, J. A., Wendler, S., Rödel, J., Pletz, M. W., Löffler, B., & Tuchscherr, L. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02762 · Cited by 110
Rubin, E. J., Herrera, C. M., Crofts, A. A., & Trent, M. S. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05052-14 · Cited by 107
Naas, T., Oxacelay, C., & Nordmann, P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00611-06 · Cited by 107
Garvey, M. I., & Piddock, L. J. V. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01644-07 · Cited by 104
Unstable Escherichia coli L Forms Revisited: Growth Requires Peptidoglycan Synthesis
Joseleau-Petit, D., Liébart, J.-C., Ayala, J. A., & D'Ari, R. (2007) · Journal of Bacteriology · doi:10.1128/jb.00273-07 · Cited by 103
Antunes, N., & Fisher, J. F. (2014) · Antibiotics · doi:10.3390/antibiotics3030398 · Cited by 98
Molecular transport through channels and pores: Effects of in-channel interactions and blocking
Bauer, W. R., & Nadler, W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601769103 · Cited by 96
Tackling drug resistance with efflux pump inhibitors: from bacteria to cancerous cells
Christena, L. R., Subramaniapillai, S. G., Ulaganathan, V., & Nagarajan, S. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1607248 · Cited by 93
Antimicrobial Stewardship and Antimicrobial Resistance
Rice, L. B. (2018) · Medical Clinics of North America · doi:10.1016/j.mcna.2018.04.004 · Cited by 91
Thanatin: An Emerging Host Defense Antimicrobial Peptide with Multiple Modes of Action
Dash, R., & Bhattacharjya, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041522 · Cited by 91
Recht, M. I., & Puglisi, J. D. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2414-2419.2001 · Cited by 89
Origin and function of penicillinase: a problem in biochemical evolution.
Pollock, M. R. (1967) · BMJ · doi:10.1136/bmj.4.5571.71 · Cited by 83
Structure of QnrB1, a Plasmid-mediated Fluoroquinolone Resistance Factor
Vetting, M. W., Hegde, S. S., Wang, M., Jacoby, G. A., Hooper, D. C., & Blanchard, J. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226936 · Cited by 83
Assembly and transport mechanism of tripartite drug efflux systems
Misra, R., & Bavro, V. N. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.02.017 · Cited by 82
Class D β-lactamases do exist in Gram-positive bacteria
Tóth, M., Antunes, N. T., Stewart, N. K., Frase, H., Bhattacharya, M., Smith, C. A., & Vakulenko, S. B. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1950 · Cited by 81
Wang, K., Pei, H., Huang, B., et al. (2012) · Current Microbiology · doi:10.1007/s00284-012-0215-3 · Cited by 78
Rox, a Rifamycin Resistance Enzyme with an Unprecedented Mechanism of Action
Koteva, K. K., Cox, G., Kelso, J., Surette, M. D., Zubyk, H. L., Ejim, L. J., Stogios, P. J., Savchenko, A. V., Sørensen, D., & Wright, G. D. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.01.009 · Cited by 76
Nagarathinam, K., Nakada-Nakura, Y., Parthier, C., Terada, T., Juge, N., Jaenecke, F., Liu, K., Hotta, Y., Miyaji, T., Omote, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06306-x · Cited by 74
Functional principles of solute transport systems: concepts and perspectives
Krämer, R. (1994) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(94)90189-9 · Cited by 71
Trieber, C. A., Burkhardt, N., Nierhaus, K. H., & Taylor, D. E. (1998) · bchm · doi:10.1515/bchm.1998.379.7.847 · Cited by 68
Varela, M. F., Sansom, C., & Griffith, J. K. (1995) · Molecular Membrane Biology · doi:10.3109/09687689509072433 · Cited by 66
Self-citationLekshmi, M., 1 QC Laboratory, H. A. P. H. T. D., Ammini, P., Adjei, J., M. Sanford, L., Shrestha, U., Kumar, S., F. Varela, M., 2 CSIR-National Institute of Oceanography (NIO), R. C., & 3 Eastern New Mexico, D. O. B. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.1.1 · Cited by 64
Self-citationBacterial Ribosomal Subunit Assembly is an Antibiotic Target
Champney, W. S. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452186 · Cited by 61
Identification of a single base change in ribosomal RNA leading to erythromycin resistance.
Vannuffel, P., Di Giambattista, M., Morgan, E. A., & Cocito, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42455-6 · Cited by 59
Selection and evolution of resistance to antimicrobial drugs
Hughes, D. (2014) · IUBMB Life · doi:10.1002/iub.1278 · Cited by 59
Bacterial Multidrug Efflux Pumps of the Major Facilitator Superfamily as Targets for Modulation
Kumar, S. H., He, G.-X., Kakarla, P., Shrestha, U., Ranjana, K. C., Ranaweera, I., Willmon, T. M., Barr, S. R., Hernandez, A. J., & Varela, M. F. (2016) · Infectious Disorders - Drug Targets · doi:10.2174/1871526516666160407113848 · Cited by 58
Self-citationPumbwe, L. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl278 · Cited by 55
Electrostatic lock in the transport cycle of the multidrug resistance transporter EmrE
Vermaas, J. V., Rempe, S. B., & Tajkhorshid, E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722399115 · Cited by 52
Structure of the EmrE multidrug transporter and its use for inhibitor peptide design
Ovchinnikov, V., Stone, T. A., Deber, C. M., & Karplus, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1802177115 · Cited by 47
Mitchell, C. J., Stone, T. A., & Deber, C. M. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00730-19 · Cited by 45
Structure, Dynamics, and Substrate Specificity of the OprO Porin from Pseudomonas aeruginosa
Modi, N., Ganguly, S., Bárcena‐Uribarri, I., Benz, R., van den Berg, B., & Kleinekathöfer, U. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.07.035 · Cited by 44
Structural comparison of bacterial multidrug efflux pumps of the major facilitator superfamily.
Ranaweera, I., Shrestha, U., Ranjana, K. C., Kakarla, P., Willmon, T. M., Hernandez, A. J., Mukherjee, M. M., Barr, S. R., & Varela, M. F. (2015) · PubMed · Cited by 36
Self-citationRise and rise of the ABC transporter families
Holland, I. B. (2019) · Research in Microbiology · doi:10.1016/j.resmic.2019.08.004 · Cited by 36
Schuldiner, S. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.02.006 · Cited by 33
Varela, M. F., & Griffith, J. K. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.6.1253 · Cited by 29
Self-citationInvolvement of hpap2 and dgkA Genes in Colistin Resistance Mediated by mcr Determinants
Gallardo, A., Ugarte‐Ruiz, M., Hernández, M., Miguela-Villoldo, P., Rodríguez-Làzaro, D., Domínguez, L., & Quesada, A. (2020) · Antibiotics · doi:10.3390/antibiotics9090531 · Cited by 23
Zwama, M., Hayashi, K., Sakurai, K., Nakashima, R., Kitagawa, K., Nishino, K., & Yamaguchi, A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02095 · Cited by 21
Strategies for discovery of new molecular targets for anti-infective drugs
Varela, M. F., & Kumar, S. H. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.04.015 · Cited by 21
Self-citationThe future of antibiotics: facing antibiotic resistance
Levy, S. B. (2000) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2000.tb02059.x · Cited by 17
The Evolution of Antibiotic Resistance
Gónzález‐Candelas, F., Comas, I., Martínez, J. L., Galán, J. C., & Baquero, F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-799942-5.00012-3 · Cited by 10
Kakarla, P., Ranjana, K. C., Shrestha, U., Ranaweera, I., Mukherjee, M. M., Willmon, T. M., Hernandez, A. J., Barr, S. R., & Varela, M. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_4 · Cited by 9
Self-citation
Cited by
Staphylococcus aureus Toxins: An Update on Their Pathogenic Properties and Potential Treatments
Ahmad-Mansour, N., Loubet, P., Pouget, C., Dunyach-Remy, C., Sotto, A., Lavigne, J.-P., & Molle, V. (2021) · Toxins · doi:10.3390/toxins13100677 · Cited by 386
Caneschi, A., Bardhi, A., Barbarossa, A., & Zaghini, A. (2023) · Antibiotics · doi:10.3390/antibiotics12030487 · Cited by 322
Halawa, E. M., Fadel, M., Al-Rabia, M. W., Behairy, A., Nouh, N. A., Abdo, M., Olga, R., Fericean, L., Atwa, A. M., El-Nablaway, M., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1305294 · Cited by 280
A Comprehensive Review of Nanomaterials: Types, Synthesis, Characterization, and Applications
(2022) · Biointerface Research in Applied Chemistry · doi:10.33263/briac131.041 · Cited by 269
Applications of Chitosan-Alginate-Based Nanoparticles—An Up-to-Date Review
Niculescu, A.-G., & Grumezescu, A. M. (2022) · Nanomaterials · doi:10.3390/nano12020186 · Cited by 197
Metadata
- Authors
- Varela, M. F., Stephen, J., Lekshmi, M., Ojha, M., Wenzel, N., Sanford, L. M., Hernandez, A. J., Parvathi, A., & Kumar, S. H.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2021-05-17
- Volume
- 10
- Issue
- 5
- Pages
- 593
- ISSN
- 2079-6382 (ISSN-L)
- OpenAlex
- W3162929884
- Cited by
- 292
- References
- 173
- FWCI
- 10.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.